Physician profile
Brian K Doerr
NPI 1437153236
$1,032.28
in general payments reported to CMS, 2019-2025
21 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $83.19 · 2021: $58.06 · 2022: $108 · 2023: $221 · 2024: $99.52 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $358.27 | 2022-2025 | Simplimax, Puraply, Novachor |
| Djo, LLC | $140.75 | 2019-2023 | Cmf |
| Horizon Therapeutics Plc | $98.13 | 2020-2022 | |
| Spinefrontier, INC. | $72.64 | 2025 | Sijfuse, Facetfuse, Nanofuse |
| Smith+Nephew, INC. | $55.88 | 2023-2024 | Collagenase Santyl, Regranex |
| Medtronic, INC. | $34.51 | 2021-2023 | Intellis Adaptivestim |
| Convatec INC. | $30.31 | 2023 | |
| Nevro Corp. | $24.89 | 2019 | |
| Averitas Pharma INC. | $23.93 | 2025 | Qutenza |
| Reprise Biomedical, INC. | $23.16 | 2023 | Miro3d |
| Abbvie INC. | $21.60 | 2024 | |
| Abbott Laboratories | $20.80 | 2025 | Eterna |
| Cashflow Solutions, LLC | $17.36 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Melinta Therapeutics, LLC | $16.68 | 2019 | |
| Ermi LLC | $15.77 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.97 | 2023 | Seglentis |
| Fidia Pharma USA INC. | $13.34 | 2024 | Hymovis, Triluron, Hyalgan |
| Paratek Pharmaceuticals, INC. | $13.14 | 2023 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $13.02 | 2019 | |
| Pfizer INC. | $13.01 | 2019 | |
| Dynasplint Systems INC. | $10.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Doerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.